Medicare Part D Issues

An additional 511 million dollars per year of taxpayer money is being spent which is not necessary. This is due to certain regulations that require Medicare Part D prescription drug plans to include all drugs of certain classes. This cost could increase substantially due to a new law that is in the works. This law entails an expansion of the number of drug classes.

Even though the intentions are good costs may rise substantially in the future. According to Cahill, this change is not necessary. Patients are already set in a manner that they may obtain required medications. According to the present regulatory guidance, there are six classes of protected drugs – antipsychotics, antidepressants, immunosuppressants, anticonvulsants, antiretrovirals and antineoplastics.
Currently the CMS requires that in the protected class of drugs, either all or substantially all of each class of drug should be included in Part D Formularies. With the passage of MIPPA, taking effect in 2010, additional medications will be protected.

Medicare Part D is basically competitive and depends on private sector drug plan sponsors for administering the prescription drug benefit.

Submit Your Comments or Questions Here